[8-K] Eastman Chemical Company Reports Material Event

Rhea-AI Filing Summary

Eastman Chemical (NYSE:EMN) filed a Form 8-K announcing the appointment of Damon Audia to its Board of Directors effective June 27 2025. Audia will serve until the 2026 Annual Meeting and join the Audit, Finance, and Environmental, Safety & Sustainability committees. Compensation will follow the standard non-employee director package disclosed in the 2025 proxy. The company confirmed no related-party transactions or family relationships. A press release detailing the appointment was furnished as Exhibit 99.1. No other material changes were reported.

0000915389false00009153892025-06-272025-06-270000915389us-gaap:CommonStockMember2025-06-272025-06-270000915389emn:A1.875notesdueNovember2026Member2025-06-272025-06-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported):

June 27, 2025

EASTMAN CHEMICAL COMPANY

(Exact Name of Registrant as Specified in Its Charter)

Delaware

1-12626

62-1539359

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

200 South Wilcox Drive
Kingsport			Tennessee			37662
(Address of Principal Executive Offices)						(Zip Code)

(423) 229-2000

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

			☐						Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
			☐						Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
			☐						Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
			☐						Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

EMN

New York Stock Exchange

1.875% Notes Due 2026

EMN26

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) On June 27, 2025, the Board of Directors (the “Board”) of Eastman Chemical Company (the “Company”) appointed Damon Audia as a director to serve until the Company’s 2026 Annual Meeting of Stockholders. He has been appointed to serve as a member of the Audit Committee, the Finance Committee, and the Environmental, Safety and Sustainability Committee of the Board. Mr. Audia will receive compensation consistent with the Company’s non-employee directors, which includes cash compensation and equity awards, as further described in the Company’s 2025 Proxy Statement filed with the Securities and Exchange Commission on March 21, 2025. Mr. Audia will also enter into an indemnification agreement with the Company.

There are no arrangements or understandings between Mr. Audia and any other persons pursuant to which he was appointed as a director. Mr. Audia does not have any family relationships with any of the Company’s directors or executive officers. There are no transactions and no proposed transactions between Mr. Audia and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Item 7.01 Regulation FD Disclosure.

On June 27, 2025, the Company issued a press release announcing Mr. Audia’s appointment to the Board as discussed in Item 5.02 of this Current Report on Form 8-K. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 (d)    Exhibits

Exhibit 99.1 is furnished pursuant to Item 9.01(d).

99.1    Press Release announcing appointment of Damon Audia as a director.

104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

						Eastman Chemical Company
			By:			/s/ Iké G. Adeyemi
						Iké G. Adeyemi
						Senior Vice President, Chief Legal Officer and Corporate Secretary
						Date: June 27, 2025

FAQ

Why did Eastman Chemical (EMN) file an 8-K on June 27 2025?

The company disclosed the appointment of Damon Audia to its Board of Directors and furnished a related press release.